AI Article Synopsis
- A 2020-2021 study in Birmingham, AL, showed that 41% of pregnant individuals had mutations linked to macrolide resistance in Mycoplasma genitalium.
- A retrospective evaluation of 203 pregnant individuals from a 1997-2001 study indicated a lower prevalence of M. genitalium at 11% with no associated resistance mutations.
- The findings highlight a significant increase in macrolide resistance mutations over time among pregnant populations in the area.
Article Abstract
In a prospective study conducted in 2020 to 2021, macrolide resistance-associated mutations were found in 41% of pregnant persons in Birmingham, AL, with Mycoplasma genitalium detected. We retrospectively evaluated M. genitalium in 203 pregnant persons participating in a study conducted in 1997 to 2001 in Birmingham and adjacent areas and found a prevalence of 11% (95% confidence interval, 6.9%-15.7%), but no macrolide resistance-associated mutations.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527314 | PMC |
| http://dx.doi.org/10.1097/OLQ.0000000000001843 | DOI Listing |
Publication Analysis
Top Keywords
mycoplasma genitalium
8
1997 2001
8
study conducted
8
macrolide resistance-associated
8
resistance-associated mutations
8
pregnant persons
8
retrospective evaluation
4
evaluation mycoplasma
4
genitalium prevalence
4
prevalence macrolide
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!